Streetbeat News

Stock Prices

IRBT

KAMN

RNAZ

TransCode Therapeutics, Inc. (RNAZ) shares fell by over 24% after pricing a common stock offering at $1.22 per share. Other stocks moved in Friday's mid-day session with notable gainers including Charge Enterprises (CRGE), Kaman Corporation (KAMN), and Mesa Air Group (MESA), among others. Losers included C3is Inc. (CISS), Azitra, Inc. (AZTR), and iRobot Corporation (IRBT). The market also reacted to various company announcements such as acquisitions, earnings reports, and analyst upgrades or downgrades.

Portfolio Pulse from Avi Kapoor

January 19, 2024 | 6:05 pm

SPY

UNG

USO

The latest U.S. Baker Hughes Oil Rig Count shows a decrease of 2 rigs, while the Gas Rig Count has increased by 3 rigs. This data provides insights into the current state of U.S. energy production and can influence energy stock prices and ETFs related to the oil and gas sector.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 6:02 pm

IBM

SLB

SMH

XLE

The CNBC Halftime Report featured final trade recommendations which included International Business Machines (IBM), Schlumberger N.V. (SLB), VanEck Semiconductor ETF (SMH), and SPDR Select Sector Fund - Energy Select Sector (XLE).

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 6:00 pm

UNH

UnitedHealth Group (NYSE:UNH) has delivered an average annual return of 15.29% over the past 20 years, outperforming the market by 7.88% annually. A $100 investment in UNH 20 years ago would be worth $1,709.55 today. The company's current market capitalization stands at $476.34 billion.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 6:00 pm

DE

Deere (NYSE:DE) has delivered an average annual return of 19.1% over the past 5 years, outperforming the market by 6.31% on an annualized basis. A $100 investment in DE 5 years ago would be worth $239.61 today. Deere's market capitalization stands at $107.24 billion.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 6:00 pm

BX

TCN

Blackstone Inc (BX) is set to acquire Tricon Residential Inc. (TCN) for $11.25 per share, a 30% premium over Tricon's closing price on January 18, 2024. The deal, involving Blackstone Real Estate Partners X and Blackstone Real Estate Income Trust, Inc. (BREIT), values Tricon's equity at $3.5 billion. Tricon will suspend its dividend and dividend reinvestment plan due to the transaction, which includes standard clauses and termination fees. Tricon will continue to be headquartered in Toronto and will be delisted from the NYSE and TSX. BX shares saw a slight increase, while TCN shares jumped by 28%.

Portfolio Pulse from Akanksha Bakshi

January 19, 2024 | 5:58 pm

AREN

Trading in shares of The Arena Group Holdings has been halted pending the release of news. Investors are awaiting further details to understand the implications of the halt.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 5:55 pm

COUR

DUOL

Goldman Sachs analyst Eric Sheridan downgraded shares of Duolingo Inc (DUOL) and Coursera Inc (COUR), citing risks from generative AI disruption in the EdTech sector. Sheridan sees traditional EdTech offerings being challenged by free, centralized content access. Duolingo's rating was lowered from Neutral to Sell with a price target of $160, and Coursera was downgraded from Neutral to Sell with a price target reduced from $18 to $14. Adjusted EBITDA margin and revenue estimates for both companies were also reduced. Shares of DUOL and COUR fell by 4.491% and 11.3%, respectively.

Portfolio Pulse from Lekha Gupta

January 19, 2024 | 5:54 pm

KSPI

Kaspi Kz Jsc ADS, represented by the ticker KSPI, has commenced trading on the US stock market.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 5:44 pm

AZN

AstraZeneca Plc (NASDAQ:AZN) announced positive results from the EMERALD-1 Phase 3 trial of Imfinzi in combination with TACE and bevacizumab for unresectable hepatocellular carcinoma (HCC). The trial showed a significant improvement in progression-free survival (PFS) compared to TACE alone. The data will be presented at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium. The safety profile was consistent with the known profiles of the medicines. AZN shares saw a slight increase of 0.06% to $66.56.

Portfolio Pulse from Vandana Singh

January 19, 2024 | 5:41 pm